After receiving chemotherapy, patients with CRCs displaying high expression of c-MYC , AP4 or MDC1 showed a trend towards decreased relapse free survival, when compared to patients with low expression of these genes in primary CRCs.
← all excerpts
AP4 suppresses DNA damage, chromosomal instability and senescence via inducing MDC1/Mediator of DNA damage Checkpoint 1 and repressing MIR22HG/miR-22-3p.
1
—
—